Flower City Capital holds a concentrated book of 49 reported positions worth $227.1M as of Q2 2026 (disclosed Jul 7, 2026, a ~7-day 13F lag). This quarter they opened Regeneron Pharmaceuticals and trimmed Vanguard S&P 500 ETF. Their largest long position is Vanguard Russell 1000 at 36% of the reported non-option book. Cloning the disclosed picks since 2024 would be +34% (+16.4%/yr). That is a simulation of the disclosed long book, not audited returns.
Growth of $10,000 cloning Flower City Capital's disclosed long 13F book, rebalanced on each filing date (so it reflects each quarter's actual reporting lag, ~7 days for the latest filing, with no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.
Top-heavy: concentrated book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
6% mapped to company sectors
+5 sectors below the cut, 1% together
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices (an exit at the prior quarter-end), no cost basis
Other tracked managers holding the same core names as Flower City Capital
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| Innovator Capital Management, LLC | 7 / 49 | $2.9B |
| Donor Advised Charitable Giving, Inc. | 9 / 49 | $4.5B |
| Swiss Re Ltd | 17 / 49 | $1.0B |
| Hoffman, Alan N Investment Management | 6 / 49 | $152.6M |
| Kearns & Associates LLC | 14 / 49 | $181.6M |
| Standpoint Asset Management, LLC | 6 / 49 | $392.5M |
| Amtrust Financial Services, Inc. | 4 / 49 | $275.6M |
| Agave Capital Management Ltd | 5 / 49 | $738.3M |
Ranked by the share of each fund's own book sitting in the names it shares with Flower City Capital: only funds sharing at least a tenth of the book qualify. Index giants, bank custody books and market makers are excluded. They hold everything, so their overlap says nothing.
Bars show each position's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Vanguard Scottsdale FDS VNG RUS1000IDX | $82.7M | 244.1K | 36.4% | ▲+1.4% Added · +3K sh | |
| 2 | Vanguard Intl Equity Index F ALLWRLD EX US | $69.3M | 826.9K | 30.5% | ▲+1.1% Added · +9K sh | |
| 3 | Vanguard Index FDS S&P 500 ETF SHS | $16.4M | 23.8K | 7.2% | ▼−1.3% Reduced · −309 sh | |
| 4 | Ishares TR CORE S&P500 ETF | $9.1M | 12.2K | 4.0% | ▼−0.8% Reduced · −103 sh | |
| 5 | Vanguard Intl Equity Index F FTSE SMCAP ETF | $6.3M | 41.1K | 2.8% | ▼−1.3% Reduced · −557 sh | |
| 6 | Ishares TR MSCI EAFE ETF | $5.9M | 56.8K | 2.6% | ▼−1.3% Reduced · −752 sh | |
| 7 | Apple Inc COM | $4.1M | 14.0K | 1.8% | ▼−6.7% Reduced · −1K sh | |
| 8 | Vanguard Admiral FDS Inc SMLLCP 600 IDX | $4.0M | 28.8K | 1.7% | ▼−0.2% Reduced · −61 sh | |
| 9 | Schwab Strategic TR US LRG CAP ETF | $3.7M | 125.6K | 1.6% | ▼−0.2% Reduced · −269 sh | |
| 10 | Vanguard Index FDS LARGE CAP ETF | $3.4M | 9.9K | 1.5% | ▲+5.5% Added · +513 sh | |
| 11 | Vanguard Star FDS VG TL INTL STK F | $1.9M | 22.3K | 0.8% | ▲+5.8% Added · +1K sh | |
| 12 | Vanguard Tax-Managed FDS VAN FTSE DEV MKT | $1.8M | 24.6K | 0.8% | —Held | |
| 13 | Nvidia Corporation COM | $1.5M | 7.4K | 0.7% | ▲+0.5% Added · +36 sh | |
| 14 | Vanguard Index FDS TOTAL STK MKT | $1.4M | 3.8K | 0.6% | ▲+0.9% Added · +35 sh | |
| 15 | Microsoft Corp COM | $1.2M | 3.1K | 0.5% | ▼−2.4% Reduced · −79 sh | |
| 16 | Vanguard Scottsdale FDS VNG RUS2000IDX | $1.1M | 9.5K | 0.5% | ▼−0.1% Reduced · −5 sh | |
| 17 | Amazon Com Inc COM | $998K | 4.2K | 0.4% | ▼−7.4% Reduced · −336 sh | |
| 18 | Schwab Strategic TR INTL EQTY ETF | $979K | 35.3K | 0.4% | —Held | |
| 19 | Vanguard Intl Equity Index F TT WRLD ST ETF | $663K | 4.2K | 0.3% | ▲+1.9% Added · +79 sh | |
| 20 | Vanguard BD Index FDS TOTAL BND MRKT | $656K | 8.9K | 0.3% | ▼−4.0% Reduced · −374 sh | |
| 21 | Vanguard Index FDS GROWTH ETF | $638K | 7.4K | 0.3% | ▲+500% Added · +6K sh | |
| 22 | Alphabet Inc CAP STK CL A | $627K | 1.8K | 0.3% | ▼−22% Reduced · −500 sh | |
| 23 | Chevron Corporation COM | $610K | 3.7K | 0.3% | ▼−3.5% Reduced · −135 sh | |
| 24 | Alphabet Inc CAP STK CL C | $532K | 1.5K | 0.2% | ▲+4.1% Added · +59 sh | |
| 25 | SPDR Series Trust ST STR P500ETF | $525K | 6.0K | 0.2% | —Held | |
| 26 | Ge Aerospace COM NEW | $500K | 1.3K | 0.2% | —Held | |
| 27 | Texas Pacific Land Corporati COM | $481K | 1.1K | 0.2% | —Held | |
| 28 | Ishares TR RUSSELL 2000 ETF | $460K | 1.5K | 0.2% | ▼−1.2% Reduced · −18 sh | |
| 29 | International Business Machs COM | $426K | 1.5K | 0.2% | ▲+29% Added · +340 sh | |
| 30 | Vanguard Index FDS SMALL CP ETF | $422K | 1.4K | 0.2% | ▲+6.4% Added · +84 sh | |
| 31 | Ishares TR U.S. TECH ETF | $409K | 1.6K | 0.2% | —Held | |
| 32 | JPMorgan Chase & Co COM | $401K | 1.2K | 0.2% | ▲+4.8% Added · +56 sh | |
| 33 | Ge Vernova Inc COM | $387K | 329 | 0.2% | —Held | |
| 34 | Berkshire Hathaway Inc Del CL B NEW | $363K | 725 | 0.2% | ▲+4.3% Added · +30 sh | |
| 35 | Schwab Strategic TR US SML CAP ETF | $329K | 9.1K | 0.1% | —Held | |
| 36 | Regeneron Pharmaceuticals COM | $312K | 500 | 0.1% | ▲New New position | |
| 37 | Schwab Strategic TR EMRG MKTEQ ETF | $304K | 8.4K | 0.1% | —Held | |
| 38 | Home Depot Inc COM | $300K | 850 | 0.1% | ▼−23% Reduced · −250 sh | |
| 39 | TPG Inc COM CL A | $290K | 7.2K | 0.1% | —Held | |
| 40 | Immuneering Corp CLASS A COM | $275K | 55.0K | 0.1% | —Held | |
| 41 | Vanguard Index FDS MID CAP ETF | $263K | 3.3K | 0.1% | ▲+299% Added · +2K sh | |
| 42 | Wheaton Precious Metals Corp COM | $239K | 2.1K | 0.1% | —Held | |
| 43 | Gravity Co Ltd SPONSORED ADS NE | $235K | 3.5K | 0.1% | —Held | |
| 44 | Walmart Inc COM | $217K | 1.9K | 0.1% | ▼−0.6% Reduced · −12 sh | |
| 45 | Aon PLC SHS CL A | $203K | 613 | 0.1% | ▲New New position | |
| 46 | Kura Oncology Inc COM | $197K | 18.0K | 0.1% | —Held | |
| 47 | Entravision Communications C CL A | $137K | 10.5K | 0.1% | ▲New New position | |
| 48 | Precigen Inc COM | $114K | 20.0K | 0.1% | —Held | |
| 49 | Outlook Therapeutics Inc COM | $32K | 20.0K | <0.1% | —Held |
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1808394/holdings"
Use Arkolith to show Flower City Capital's latest holdings, largest changes, and filing provenance.
As-of date vs the date the SEC received each filing
Reported 13F total per quarter. Raw filing totals can include option notional.
| Quarter | As of | Filed | Lag | Positions | Value | Form |
|---|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Jul 7, 2026 | 7d | 49 | $227.1M | 13F-HR |
| Q1 2026 | Mar 31, 2026 | Apr 14, 2026 | 14d | 46 | $199.3M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Jan 22, 2026 | 22d | 44 | $196.1M | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Oct 8, 2025 | 8d | 43 | $186.0M | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Jul 16, 2025 | 16d | 39 | $169.6M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | Apr 22, 2025 | 22d | 38 | $152.5M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Jan 16, 2025 | 16d | 34 | $163.5M | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Oct 15, 2024 | 15d | 33 | $170.3M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. Book totals and portfolio weights cover reported non-option positions, which can include notes and warrants. Disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.